Mostrar el registro sencillo del ítem

dc.contributor.authorDueñas-Castell, Carmelospa
dc.contributor.authorCoronell, Wilfridospa
dc.contributor.authorBorré-Naranjo, Dianaspa
dc.contributor.authorAlmanza, Amilkarspa
dc.contributor.authorLora Lián, Leydisspa
dc.contributor.authorNavarro, Rafaelspa
dc.contributor.authorRojas-Suarez, Josespa
dc.date.accessioned2022-04-15 00:00:00
dc.date.available2022-04-15 00:00:00
dc.date.issued2022-04-15
dc.identifier.issn2215-7840
dc.description.abstractIntroducción: hasta la fecha, pocos estudios informaron variaciones máximas en la infección por COVID-19 en países de ingresos bajos y medios. Nuestro objetivo fue explorar las posibles razones de los cambios epidemiológicos con el tiempo. Métodos: este estudio se realizó en un centro de referencia de tercer nivel en Cartagena, Colombia, entre el 7 de marzo de 2020 y el 28 de febrero de 2021. Se incluyeron pacientes adultos con sospecha o confirmación de COVID-19. Categorizamos el período de estudio en dos según los picos definidos en Colombia: el primer período abarcó las semanas epidemiológicas 10-35 (7 de marzo al 30 de agosto de 2020) y el segundo período abarcó las semanas 36 a 60 (1 de septiembre de 2020 - 28 de febrero de 2021). Ajustamos la mortalidad por covariables para identificar posibles cambios. Resultados: en total, 2761 pacientes con COVID-19 fueron hospitalizados. Comparando los dos períodos, el número de casos fue mayor durante la semana 21 (pico 1: 121 pacientes) y la semana 50 (pico 2: 128 pacientes), respectivamente. La tasa de mortalidad disminuyó del 16,5 % (IC del 95 %: 13,3 a 19,8) en la semana 10 al 8,91 (IC del 95 %: 6,95 a 10,8) en la semana 60 (valor de p <0,001). Conclusión: nuestro estudio es el primero en informar un seguimiento de un año durante la pandemia de CO-VID-19 en un país de ingresos bajos y medios. Encontramos una menor tasa de mortalidad durante el segundo período, posiblemente explicada por un aumento en la experiencia y una mejor organización con los recursos de salud. spa
dc.description.abstractIntroduction: to date, few studies reported peak variations in COVID-19 infection in low-and middle-income countries. We aimed to explore the potential reasons for epidemiological changes with time. Methods: this study was conducted at a tertiary referral center in Cartagena, Colombia, between March 7, 2020 and February 28, 2021. Were included adult patients with suspected or confirmed COVID-19. We categorized the study period into two according to the peaks defined in Colombia: the first period included epidemiological weeks 10-35 (March 7, 2020 - August 30, 2020), and the second period included weeks 36-60 (September 1, 2020 - February 28, 2021). We adjusted the mortality by covariates to identify potential changes. Results: in total, 2761 COVID-19 patients were hospitalized. Comparing the two periods, the number of cases was higher during week 21 (peak1: 121 patients) and week 50 (peak2: 128 patients), respectively. The mortality rate declined from 16.5% (95% CI 13.3-19.8) in week 10 to 8.91 (CI 95% 6.95-10.8) in week 60 (p-value <0.001). Conclusions: our study is the first to report a one-year follow-up during the COVID-19 pandemic in a low-and middle-income country. We found a lower mortality rate during the second period, possibly explained by an increase in the experience and a better organization with health resources. eng
dc.format.mimetypeapplication/pdfeng
dc.language.isoengeng
dc.publisherUniversidad de Cartagenaspa
dc.relation.ispartofjournalRevista Ciencias Biomédicasspa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0eng
dc.sourcehttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/3932eng
dc.subjectCOVID-19eng
dc.subjectReverse Transcriptase Polymerase Chain Reactioneng
dc.subjectpatient admissioneng
dc.subjectpandemicseng
dc.subjectCOVID-19spa
dc.subjectReacción en cadena de la polimerasa con transcriptasa inversaspa
dc.subjectadmisión de pacientesspa
dc.subjectpandemiasspa
dc.titleVariaciones hospitalarias durante el primer año de la pandemia de COVID-19 en un hospital de referencia en un país de ingresos bajos a medios: un gran estudio de cohorte de un solo centrospa
dc.typeArtículo de revistaspa
dc.title.translatedHospital variations during the first year of the COVID-19 pandemic in a referral hospital in a low-to-middle-income country: a large single-center cohort studyeng
dc.identifier.doi10.32997/rcb-2022-3932
dc.type.versioninfo:eu-repo/semantics/publishedVersioneng
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85eng
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2eng
dc.identifier.eissn2389-7252
dc.identifier.urlhttps://doi.org/10.32997/rcb-2022-3932
dc.relation.bitstreamhttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/3932/3197
dc.relation.citationeditionNúm. 2 , Año 2022spa
dc.relation.citationendpage114
dc.relation.citationissue2spa
dc.relation.citationstartpage103
dc.relation.citationvolume11spa
dc.relation.referencesLi J, Huang DQ, Zou B, Yang H, Hui WZ, Rui F, et al. Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol. 2021; 93:1449-58. DOI: 10.1002/jmv.26424eng
dc.relation.referencesMishra SK, Tripathi T. One year update on the COVID-19 pandemic: Where are we now? Acta Trop. 2021; 214:105778. DOI: 10.1016/j.actatropica.2020.105778eng
dc.relation.referencesCook AH, Cohen DB. Pandemic Disease: A Past and Future Challenge to Governance in the United States. Rev Policy Res. 2008; 25:449-71. DOI: 10.1111/j.1541-1338.2008.00346.xeng
dc.relation.referencesBaber R. Pandemics: learning from the past. Climacteric. 2020; 23:211-2. DOI: 10.1080/13697137.2020.1756586eng
dc.relation.referencesSaavedra Trujillo CH. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio. 2020; 24:1. DOI: http://dx.doi.org/10.22354/in.v24i3.851eng
dc.relation.referencesAccini Mendoza JL, Nieto Estrada VH, Beltrán López N, Ramos Bolaños E, Molano Franco D, Dueñas Castell C, et al. Actualización de la Declaración de consenso en medicina critica para la atención multidisciplinaria del paciente con sospecha o confirmación diagnóstica de COVID-19. Acta Colombiana de Cuidado Intensivo. 2020; 20:1-112. doi: 10.1016/j.acci.2020.09.004eng
dc.relation.referencesSaito S, Saito N, Itoga M, Ozaki H, Kimura T, Okamura Y, et al. Influence of Media on Seasonal Influenza Epidemic Curves. Int J Infect Dis. 2016; 50:6-9. doi: 10.1016/j.physa.2018.08.113eng
dc.relation.referencesPetrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966. doi: https://doi.org/10.1136/bmj.m1966eng
dc.relation.referencesSimonsen L, Fukuda K, Schonberger LB, Cox NJ. The impact of influenza epidemics on hospitalizations. J Infect Dis. 2000; 181:831-7. DOI: 10.1086/315320eng
dc.relation.referencesZhou H, Thompson WW, Viboud CG, Ringholz CM, Cheng P-Y, Steiner C, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis. 2012; 54:1427-36. DOI: 10.1093/cid/cis211eng
dc.relation.referencesJi Y, Ma Z, Peppelenbosch MP, Pan Q. Potential association between COVID-19 mortality and healthcare resource availability. Lancet Glob Health. 2020; 8: e480. DOI: 10.1016/S2214-109X(20)30068-1eng
dc.relation.referencesImmovilli P, Morelli N, Rota E, Guidetti D. COVID-19 mortality and healthcare resources: Organization. Medicina intensiva. 2020; doi: 10.1016/j.medin.2020.05.014eng
dc.relation.referencesThakur B, Dubey P, Benitez J, Torres JP, Reddy S, Shokar N, et al. A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19. Sci Rep. 2021; 11:8562. https://doi.org/10.1038/s41598-021-88130-weng
dc.relation.referencesSuleyman G, Fadel RA, Malette KM, Hammond C, Abdulla H, Entz A, et al. Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit. JAMA Netw open. 2020; 3:e2012270. Doi: 10.1001/jamanetworkopen.2020.12270eng
dc.relation.referencesCheng MP, Papenburg J, Desjardins M, Kanjilal S, Quach C, Libman M, et al. Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus 2: A Narrative Review. Ann Intern Med. 2020; 172:726-34. DOI: 10.7326/M20-1301eng
dc.relation.referencesCorman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020; 25:2000045. DOI: 10.2807/1560-7917.ES.2020.25.3.2000045eng
dc.relation.referencesWang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020; 323:1843-4. DOI: 10.1001/jama.2020.3786eng
dc.relation.referencesChopra KK, Arora VK. Covid-19 and social stigma: Role of scientific community. Indian J Tuberc. 2020; 67:284-5. DOI: 10.1016/j.ijtb.2020.07.012eng
dc.relation.referencesKi M. Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea. Epidemiol Health. 2020;42: e2020007. DOI: 10.4178/epih.e2020007eng
dc.relation.referencesChersich MF, Gray G, Fairlie L, Eichbaum Q, Mayhew S, Allwood B, et al. COVID-19 in Africa: care and protection for frontline healthcare workers. Global Health. 2020; 16:46. DOI https://doi.org/10.1186/s12992-020-00574-3eng
dc.relation.referencesvan Halem K, Bruyndonckx R, van der Hilst J, Cox J, Driesen P, Opsomer M, et al. Risk factors for mortality in hospitalized patients with COVID-19 at the start of the pandemic in Belgium: a retrospective cohort study. BMC Infect Dis. 2020; 20:897. DOI: 10.1186/s12879-020-05605-3eng
dc.rights.accessrightsinfo:eu-repo/semantics/openAccesseng
dc.rights.creativecommonsEsta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.eng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501eng
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1eng
dc.type.contentTexteng
dc.type.driverinfo:eu-repo/semantics/articleeng
dc.type.localJournal articleeng
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTeng


Ficheros en el ítem

FicherosTamañoFormatoVer
Rev Cienc Biomed-3932.pdf1.098Mbapplication/pdfVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

https://creativecommons.org/licenses/by-nc-sa/4.0
Excepto si se señala otra cosa, la licencia del ítem se describe como https://creativecommons.org/licenses/by-nc-sa/4.0